However, there is no information about whether the levels of IL-37 in the CFS and peripheral blood alter during the pathogenic process of GBS and how the changes in the levels of CSF and plasma IL-37 are associated with disease activity in GBS patients. This evidence concerns the gene IL37 and myalgic encephalomeyelitis/chronic fatigue syndrome.